Jiaxin Yang

7PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 19, 2025
Does delayed surgery affect survival in recurrent ovarian adult-type granulosa cell tumor? A retrospective study from a high-volume medical center.

Kezhen Zhang, Xuan Zong, Jing Zheng

|May 12, 2025
Role of adjuvant chemotherapy in stage IC ovarian granulosa cell tumors: a systematic review and meta-analysis.

Tianyu Zhang, Jie Yang, Xinyue Zhang

|Feb 09, 2025
Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysis.

Xinyue Zhang, Jie Yang, Sijian Li

|Jan 10, 2025
Ovarian squamous cell carcinoma: clinicopathological features, prognosis and immunotherapy outcomes.

Tianyu Zhang, Jie Yang, Sijian Li

|Nov 01, 2024
Toripalimab combined with bevacizumab plus chemotherapy as first-line treatment for refractory recurrent or metastatic cervical cancer: a single-arm, open-label, phase II study (JS001-ISS-CO214).

Chen Li, Shikai Liu, Yonglan He

|Oct 25, 2024
Humanized patient-derived xenograft mouse model bearing ovarian clear cell carcinoma.

Zhen Yuan, Huimei Zhou, Dongyan Cao

Pageof 2

Frequent Collaborators

4 joint publications

Jie Yang

3 joint publications

Dongyan Cao

3 joint publications

Tianyu Zhang

2 joint publications

Sijian Li